在線客服
+400-6900-195
英文版
Toggle navigation
首頁
產品與服務
吉瑪產品
siRNA產品
shRNA產品
miRNA產品
慢病毒產品
熒光定量PCR產品
miRNA質粒產品
腺病毒產品
腺相關病毒產品-AAV
全基因合成
RNA FISH常規試劑盒
即成型產品
蛋白檢測及抗體類
吉瑪服務
細胞實驗服務
高通量測序
高通量篩選服務
動物實驗服務
信息核對
技術支持
操作手冊
常見問題
操作視頻
高分文集
報告單
訂購商城
用戶注冊
用戶登錄
吉瑪訂購表
投資者入口
關于我們
誠聘英才
聯系我們
銷售網絡
RNA藥物研發
技術支持
數字ELISA
Toggle Dropdown
神經科學
腫瘤學
免疫學
傳染病
心臟病學
其他
High serum neurofilament levels are observed close to disease activity events in pediatric-onset MS and MOG antibody-associated diseases. Mult Scler Relat Disord. 2023 Jun;74:104704. doi: 10.1016/j.msard.2023.104704.(IF 4.8)
The contribution of neurofilament light chain to better characterize pediatric multiple sclerosis (editorial on: Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trial). Mult Scler. 2023 May;29(6):668-670. doi: 10.1177/13524585231161148. (IF 5.85)
Plasma neurofilament light significantly decreases following treatment in Lyme neuroborreliosis and is not associated with persistent symptoms. Eur J Neurol. 2023 May;30(5):1371-1377. doi: 10.1111/ene.15707.(IF 6.28)
Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patients. J Cereb Blood Flow Metab. 2023 Apr 27:271678X231172520. doi: 10.1177/0271678X231172520. (IF 6.96)
Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood. Clin Chem Lab Med. 2023 Jan 31;61(7):1245-1254. doi: 10.1515/cclm-2022-1181.(IF 8.49)
Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts. Alzheimers Res Ther. 2023 Mar 10;15(1):48. doi: 10.1186/s13195-023-01201-0.(IF 8.8)
The dynamics of plasma biomarkers across the Alzheimer's continuum. Alzheimers Res Ther. 2023 Feb 8;15(1):31. doi: 10.1186/s13195-023-01174-0.(IF 8.8)
Head-to-head comparison of 6 plasma biomarkers in early multiple system atrophy. NPJ Parkinsons Dis. 2023 Mar 15;9(1):40. doi: 10.1038/s41531-023-00481-5. (IF 9.3)
Plasma GFAP in Parkinson's disease with cognitive impairment and its potential to predict conversion to dementia. NPJ Parkinsons Dis. 2023 Feb 9;9(1):23. doi: 10.1038/s41531-023-00447-7.(IF 9.3)
Plasma Neurofilament Light Chain Predicts Mortality and Long-Term Neurological Outcomes in Patients with Intracerebral Hemorrhage. Aging Dis. 2023 Apr 1;14(2):560-571. doi: 10.14336/AD.2022.21020.(IF 9.96)
Rapid Activation of Neuroinflammation in Stroke: Plasma and Extracellular Vesicles Obtained on a Mobile Stroke Unit. Stroke. 2023 Mar;54(3):e52-e57. doi: 10.1161/STROKEAHA.122.041422.(IF 10.17)
Association of CSF and Serum Neurofilament Light and Glial Fibrillary Acidic Protein, Injury Severity, and Outcome in Spinal Cord Injury. Neurology. 2023 Mar 21;100(12):e1221-e1233. doi: 10.1212/WNL.0000000000206744.(IF 11.8)
Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials. Neurology. 2023 Jul 4;101(1):38-45. doi: 10.1212/WNL.0000000000207115. (IF 11.8)
Elevated plasma p-tau181 levels unrelated to Alzheimer's disease pathology in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2023 Jun;94(6):428-435. doi: 10.1136/jnnp-2022-330709. (IF 13.65)
Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis. J Neurol Neurosurg Psychiatry. 2023 Apr 19:jnnp-2022-330796. doi: 10.1136/jnnp-2022-330796. (IF 13.65)
Plasma biomarkers for Alzheimer's disease: a field-test in a memory clinic. J Neurol Neurosurg Psychiatry. 2023 Jun;94(6):420-427. doi: 10.1136/jnnp-2022-330619. (IF 13.65)
Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function. J Neurol Neurosurg Psychiatry. 2023 Jun;94(6):411-419. doi: 10.1136/jnnp-2022-330540.(IF 13.65)
Predicting amyloid PET and tau PET stages with plasma biomarkers. Brain. 2023 May 2;146(5):2029-2044. doi: 10.1093/brain/awad042.(IF 15.25)
Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease. Alzheimers Dement. 2023 Apr 20. doi: 10.1002/alz.13026. (IF 16.65)
Prospective evaluation of plasma phosphorylated tau in a real-life memory clinic in Thailand. Alzheimers Dement. 2023 Jun;19(6):2745-2749. doi: 10.1002/alz.13022.(IF 16.65)
Plasma neurofilament light is a predictor of neurological outcome 12 h after cardiac arrest. Crit Care. 2023 Feb 24;27(1):74. doi: 10.1186/s13054-023-04355-3.(IF 19.33)
Alzheimer Disease Blood Biomarkers in Patients With Out-of-Hospital Cardiac Arrest. JAMA Neurol. 2023 Apr 1;80(4):388-396.(IF 29.9)
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis. JAMA Neurol. 2023 Feb 6;80(3):287–97. doi: 10.1001/jamaneurol.2022.5250. (IF 29.9)
欄目
操作手冊
常見問題
操作視頻
高分文集
?
久久久久久久精品成人热